![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 60, Issue 5, 955-962, November 2001
-Adrenergic Receptor Subtypes in
Blood Vessels of Knockout Mice Lacking 1- or
2-Adrenergic Receptors
Howard Hughes Medical Institute, Stanford University, Stanford,
California (A.C., B.K.K.); and Department of Pharmacology, University
of Würzburg, Würzburg, Germany (M.E.B., L.M., M.J.L., L.H.)
-Adrenergic receptors (-AR) are essential regulators of
cardiovascular homeostasis. In addition to their prominent function in
the heart, -AR are located on vascular smooth muscle cells, where
they mediate vasodilating effects of endogenous catecholamines. In this
study, we have investigated in an isometric myograph different types of
blood vessels from mice lacking 1- and/or
2-adrenergic receptor subtypes (1-KO,
2-KO, 12-KO). In wild-type
mice, isoproterenol induced relaxation of segments from thoracic aorta, carotid, femoral and pulmonary arteries, and portal vein. The relaxant
effect of -receptor stimulation was absent in femoral and pulmonary
arteries from 1-KO mice. In aortic and carotid arteries
and in portal veins, the vasodilating effect of isoproterenol was
reduced in mice lacking 1- or
2-receptors. However, in these vessels the vasodilating
effect was only abolished in double KO mice lacking both
1- and 2-receptors. Vessel relaxation
induced by forskolin did not differ between wild-type and KO mice.
Similar contributions of 1- and
2-receptors to isoproterenol-induced vasorelaxation were
found when vessels from KO mice were compared with wild-type arteries
in the presence of subtype-selective -receptor antagonists. These
studies demonstrate that 1-adrenergic receptors play a
dominant role in the murine vascular system to mediate vasodilation.
Surprisingly, 2-receptors contribute to adrenergic vasodilation only in a few major blood vessels, suggesting that differential distribution of -adrenergic receptor subtypes may play
an important role in redirection of tissue perfusion.
This article has been cited by other articles:
|
|
 |
|
  E. Oliver, D. Marti, F. Monto, N. Flacco, L. Moreno, D. Barettino, M. D. Ivorra, and P. D'Ocon The Impact of {alpha}1-Adrenoceptors Up-Regulation Accompanied by the Impairment of {beta}-Adrenergic Vasodilatation in Hypertension J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 982 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. I. Cohn, D. M. Harris, S. Pesant, M. Pfeiffer, R.-H. Zhou, W. J. Koch, G. W. Dorn 2nd, and A. D. Eckhart Inhibition of vascular smooth muscle G protein-coupled receptor kinase 2 enhances {alpha}1D-adrenergic receptor constriction Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1695 - H1704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Xu, O. Platoshyn, A. Makino, W. H. Dillmann, K. Akassoglou, C. V. Remillard, and J. X.-J. Yuan Characterization of agonist-induced vasoconstriction in mouse pulmonary artery Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H220 - H228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Leblais, E. Delannoy, F. Fresquet, H. Begueret, N. Bellance, S. Banquet, C. Allieres, L. Leroux, C. Desgranges, A. Gadeau, et al. {beta}-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent {beta}2 component in pulmonary hypertension Cardiovasc Res, January 1, 2008; 77(1): 202 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Wang, P. Jose, and C. S. Wilcox beta1 Receptors Protect the Renal Afferent Arteriole of Angiotensin-Infused Rabbits from Norepinephrine-Induced Oxidative Stress J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3347 - 3354. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D'Angelo, J. D. Mintz, J. E. Tidwell, A. M. Schreihofer, D. M. Pollock, and D. W. Stepp Exaggerated Cardiovascular Stress Responses and Impaired {beta}-Adrenergic-Mediated Pressor Recovery in Obese Zucker Rats Hypertension, December 1, 2006; 48(6): 1109 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. M. T. Hare, J. M. A. Worrall, A. J. Baker, E. Liu, N. Sikich, and C. D. Mazer {beta}2 Adrenergic antagonist inhibits cerebral cortical oxygen delivery after severe haemodilution in rats Br. J. Anaesth., November 1, 2006; 97(5): 617 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. K. Salem, P. Ranjzad, A. Driessen, C. E. Appleby, A. M. Heagerty, and P. A. Kingston Beta-Adrenoceptor Blockade Markedly Attenuates Transgene Expression From Cytomegalovirus Promoters Within the Cardiovascular System Arterioscler Thromb Vasc Biol, October 1, 2006; 26(10): 2267 - 2274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Luksha, L. Poston, J.-A. Gustafsson, L. Aghajanova, and K. Kublickiene Gender-Specific Alteration of Adrenergic Responses in Small Femoral Arteries From Estrogen Receptor-{beta} Knockout Mice Hypertension, November 1, 2005; 46(5): 1163 - 1168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Robert, V. Thoreau, C. Norez, A. Cantereau, A. Kitzis, Y. Mettey, C. Rogier, and F. Becq Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Channel by {beta}-Adrenergic Agonists and Vasoactive Intestinal Peptide in Rat Smooth Muscle Cells and Its Role in Vasorelaxation J. Biol. Chem., May 14, 2004; 279(20): 21160 - 21168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Lohse, S. Engelhardt, and T. Eschenhagen What Is the Role of {beta}-Adrenergic Signaling in Heart Failure? Circ. Res., November 14, 2003; 93(10): 896 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2002; 23(4): 594 - 597. [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. A. Janssen and J. F. M. Smits Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2002; 282(6): R1545 - R1564. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
